The company’s product portfolio is anchored by Eylea, used in treating various eye diseases ... Should you invest in REGN right now? Consider this first: Investing.com’s ProPicks, an AI ...

The company’s product portfolio is anchored by Eylea, used in treating various eye diseases, and Dupixent ... Should you invest in REGN right now? Consider this first: Investing.com’s ProPicks, an ...

Unity’s restructuring comes along with 36-week results from its phase 2b Aspire trial that weighed its investigational eye treatment UBX1325 against Regeneron’s blockbuster Eylea in patients ...

Earlier this year, biotech company 23andMe filed for bankruptcy. The harsh reality was that its business, while enticing to people who wanted to learn about their backgrounds via DNA testing kits, ...

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies ...

US President Donald Trump’s tariff hammer against the European Union caused stock markets to falter at the close of the ...

Using your body’s antibody factories with new gene instructions for anti-VEGF antibodies is right around the corner and ... FDA approves first interchangeable biosimilars to Eylea to treat macular ...

German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of ...

The company’s product portfolio is anchored by Eylea, used in treating various eye diseases, and Dupixent, which has shown significant growth potential across multiple indications. In the first ...

a complete response letter in the US for Eylea HD's prefilled syringe, and a funding gap at Good Days, a large copay assistance organization that supports US eye drug sales. On the bright side ...